Given its bacteriostatic and pain-relieving characteristics, the amnion membrane is commonly employed in wound healing. In recent years, increased awareness has resulted in an increase in the number of transplants, increasing demand for these tissue-based goods. Amniotic membranes are typically utilized for purposes such as conjunctival surface reconstruction, pterygium excisions, surgical wounds, corneal ulcers, pressure and venous leg ulcers, limbal stem cell deficiency, and regenerative medicine, among others.
Data Bridge Market Research analyses that the Global amniotic products market is growing with a CAGR of 8.6% in the forecast period of 2022 to 2029 and is expected to reach USD 1,558.83 million by 2029.
“Growing cases of burn wounds is bolstering the market growth”
As the occurrence of burn wounds has increased, so has the demand for wound care biologics such as amniotic membranes. According to the WHO, the majority of burn cases occur in low- and middle-income countries, with over two-thirds occurring in the WHO African and Southeast Asian regions. Every year, 1 million Indians suffer from mild to severe burns (Source: WHO). Other Southeast Asian countries with high burn incidence rates include Bangladesh and Nepal. Every year, an estimated 173,000 children in Bangladesh suffer from mild to severe burns. In Nepal, burns are the second most common injury, accounting for 5% of all disabilities.
What restraints the growth of the Global Amniotic Products Market?
“COVID-19 restrained the market growth"
The outbreak of COVID-19 had a detrimental impact on the overall amniotic goods market in 2021 due to national lockdowns. As a result of the lockdowns, wound care services are unavailable and elective procedures are postponed or cancelled. During the epidemic, elective procedures were postponed or cancelled in order to refocus or reserve available resources and capacities, such as patient care experts and hospital beds, for COVID-19 patient care.
Segmentation: Global Amniotic Products Market
Global amniotic products market is categorized into seven notable segments based on the product type, application, adherence type, site, end user, and distribution channel.
- On the basis of product type, the global amniotic products market is segmented into amniotic membranes and amniotic suspensions.
- On the basis of type, the global amniotic products market is segmented into flowables and non-flowabales.
- On the basis of application, the global amniotic products market is segmented into wound care, orthopedics, ophthalmology, periodontal, regenerative medicines, prenatal diagnosis, stem cell biology and others.
- On the basis of adherence type, the global amniotic products market is segmented into with sutures and without sutures.
- On the basis of site, the global amniotic products market is segmented into with topical and internal.
- On the basis of end user, the global amniotic products market is segmented into hospital, clinics, research institutes, home care and others.
- On the basis of distribution channel, the global amniotic products market is segmented into direct tender and third party distributor.
Regional Insights: North America dominates the global amniotic products market
The market is dominated by North America. The presence of leading market companies in North America, as well as well-established healthcare facilities, are the primary factors driving regional market growth. Increased emphasis on alternative technologies, as well as the adoption of new technologies, are projected to drive market expansion in this area over the forecast period.
Over the forecast period, Asia-Pacific is expected to develop at a considerable CAGR. The majority of the countries in this region are economically developing, and disposable income is steadily increasing. Several global corporations have made significant investments in this region. Furthermore, substantial unmet demands, as well as increasing healthcare infrastructure, particularly in Japan and India, are expected to drive market expansion.
To know more about the study, visit, https://www.databridgemarketresearch.com/fr/reports/global-amniotic-products-market
The Prominent Key Players Operating in the Global Amniotic Products Market Include:
- MIMEDX (U.S.)
- Smith+Nephew (U.K.)
- Organogenesis Inc. (U.S.)
- Integra LifeSciences (U.S.)
- Stryker (U.S.)
- APPLIED BIOLOGICS (U.S.)
- Katena Products. Inc. (U.S.)
- Lucina BioSciences (U.S.)
- Skye Biologics Holdings, LLC. (U.S.)
- Surgenex, LLC. (U.S.)
- Ventris Medical, LLC. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global amniotic products market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Amniotic Products Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
